Global Artificial Intelligence Health Risk Management Platform 麻豆原创 Growth (Status and Outlook) 2024-2030

Publication ID:

LPI11243904

Publication Date:

November 8, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

The AI 鈥嬧€媓ealth risk management platform is a tool based on AI technology that aims to predict and assess the health risks of individuals or groups by integrating and analyzing a variety of health data (such as electronic health records, genetic data, lifestyle information, etc.). The platform can identify potential health problems, provide personalized prevention advice and intervention measures, and help medical institutions and individuals conduct more proactive health management and reduce disease incidence and medical costs.
The global Artificial Intelligence Health Risk Management Platform market size is projected to grow from US$ 22880 million in 2024 to US$ 70190 million in 2030; it is expected to grow at a CAGR of 20.5% from 2024 to 2030.
The 鈥淎rtificial Intelligence Health Risk Management Platform Industry Forecast鈥� looks at past sales and reviews total world Artificial Intelligence Health Risk Management Platform sales in 2022, providing a comprehensive analysis by region and market sector of projected Artificial Intelligence Health Risk Management Platform sales for 2023 through 2029. With Artificial Intelligence Health Risk Management Platform sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artificial Intelligence Health Risk Management Platform industry.
This Insight Report provides a comprehensive analysis of the global Artificial Intelligence Health Risk Management Platform landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Artificial Intelligence Health Risk Management Platform portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Artificial Intelligence Health Risk Management Platform market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artificial Intelligence Health Risk Management Platform and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artificial Intelligence Health Risk Management Platform.
United States market for Artificial Intelligence Health Risk Management Platform is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Artificial Intelligence Health Risk Management Platform is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Artificial Intelligence Health Risk Management Platform is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Artificial Intelligence Health Risk Management Platform players cover IBM, Health Catalyst, Verisk, Evolent, Optum, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Intelligence Health Risk Management Platform market by product type, application, key players and key regions and countries.
Segmentation by Type:
Cloud-Based
On-Premises
Segmentation by Application:
Adults
Children
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Cloud-Based
On-Premises
Segmentation by Application:
Adults
Children
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
IBM
Health Catalyst
Verisk
Evolent
Optum
Ayasdi
Cleerly
Health at Scale

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Artificial Intelligence Health Risk Management Platform 麻豆原创 Size 2019-2030
2.1.2 Artificial Intelligence Health Risk Management Platform 麻豆原创 Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Artificial Intelligence Health Risk Management Platform by Country/Region, 2019, 2023 & 2030
2.2 Artificial Intelligence Health Risk Management Platform Segment by Type
2.2.1 Cloud-Based
2.2.2 On-Premises
2.3 Artificial Intelligence Health Risk Management Platform 麻豆原创 Size by Type
2.3.1 Artificial Intelligence Health Risk Management Platform 麻豆原创 Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Artificial Intelligence Health Risk Management Platform 麻豆原创 Size 麻豆原创 Share by Type (2019-2024)
2.4 Artificial Intelligence Health Risk Management Platform Segment by Application
2.4.1 Adults
2.4.2 Children
2.5 Artificial Intelligence Health Risk Management Platform 麻豆原创 Size by Application
2.5.1 Artificial Intelligence Health Risk Management Platform 麻豆原创 Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Artificial Intelligence Health Risk Management Platform 麻豆原创 Size 麻豆原创 Share by Application (2019-2024)
3 Artificial Intelligence Health Risk Management Platform 麻豆原创 Size by Player
3.1 Artificial Intelligence Health Risk Management Platform 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Artificial Intelligence Health Risk Management Platform Revenue by Player (2019-2024)
3.1.2 Global Artificial Intelligence Health Risk Management Platform Revenue 麻豆原创 Share by Player (2019-2024)
3.2 Global Artificial Intelligence Health Risk Management Platform Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Artificial Intelligence Health Risk Management Platform by Region
4.1 Artificial Intelligence Health Risk Management Platform 麻豆原创 Size by Region (2019-2024)
4.2 Global Artificial Intelligence Health Risk Management Platform Annual Revenue by Country/Region (2019-2024)
4.3 Americas Artificial Intelligence Health Risk Management Platform 麻豆原创 Size Growth (2019-2024)
4.4 APAC Artificial Intelligence Health Risk Management Platform 麻豆原创 Size Growth (2019-2024)
4.5 Europe Artificial Intelligence Health Risk Management Platform 麻豆原创 Size Growth (2019-2024)
4.6 Middle East & Africa Artificial Intelligence Health Risk Management Platform 麻豆原创 Size Growth (2019-2024)
5 Americas
5.1 Americas Artificial Intelligence Health Risk Management Platform 麻豆原创 Size by Country (2019-2024)
5.2 Americas Artificial Intelligence Health Risk Management Platform 麻豆原创 Size by Type (2019-2024)
5.3 Americas Artificial Intelligence Health Risk Management Platform 麻豆原创 Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artificial Intelligence Health Risk Management Platform 麻豆原创 Size by Region (2019-2024)
6.2 APAC Artificial Intelligence Health Risk Management Platform 麻豆原创 Size by Type (2019-2024)
6.3 APAC Artificial Intelligence Health Risk Management Platform 麻豆原创 Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Artificial Intelligence Health Risk Management Platform 麻豆原创 Size by Country (2019-2024)
7.2 Europe Artificial Intelligence Health Risk Management Platform 麻豆原创 Size by Type (2019-2024)
7.3 Europe Artificial Intelligence Health Risk Management Platform 麻豆原创 Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Artificial Intelligence Health Risk Management Platform by Region (2019-2024)
8.2 Middle East & Africa Artificial Intelligence Health Risk Management Platform 麻豆原创 Size by Type (2019-2024)
8.3 Middle East & Africa Artificial Intelligence Health Risk Management Platform 麻豆原创 Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Artificial Intelligence Health Risk Management Platform 麻豆原创 Forecast
10.1 Global Artificial Intelligence Health Risk Management Platform Forecast by Region (2025-2030)
10.1.1 Global Artificial Intelligence Health Risk Management Platform Forecast by Region (2025-2030)
10.1.2 Americas Artificial Intelligence Health Risk Management Platform Forecast
10.1.3 APAC Artificial Intelligence Health Risk Management Platform Forecast
10.1.4 Europe Artificial Intelligence Health Risk Management Platform Forecast
10.1.5 Middle East & Africa Artificial Intelligence Health Risk Management Platform Forecast
10.2 Americas Artificial Intelligence Health Risk Management Platform Forecast by Country (2025-2030)
10.2.1 United States 麻豆原创 Artificial Intelligence Health Risk Management Platform Forecast
10.2.2 Canada 麻豆原创 Artificial Intelligence Health Risk Management Platform Forecast
10.2.3 Mexico 麻豆原创 Artificial Intelligence Health Risk Management Platform Forecast
10.2.4 Brazil 麻豆原创 Artificial Intelligence Health Risk Management Platform Forecast
10.3 APAC Artificial Intelligence Health Risk Management Platform Forecast by Region (2025-2030)
10.3.1 China Artificial Intelligence Health Risk Management Platform 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Artificial Intelligence Health Risk Management Platform Forecast
10.3.3 Korea 麻豆原创 Artificial Intelligence Health Risk Management Platform Forecast
10.3.4 Southeast Asia 麻豆原创 Artificial Intelligence Health Risk Management Platform Forecast
10.3.5 India 麻豆原创 Artificial Intelligence Health Risk Management Platform Forecast
10.3.6 Australia 麻豆原创 Artificial Intelligence Health Risk Management Platform Forecast
10.4 Europe Artificial Intelligence Health Risk Management Platform Forecast by Country (2025-2030)
10.4.1 Germany 麻豆原创 Artificial Intelligence Health Risk Management Platform Forecast
10.4.2 France 麻豆原创 Artificial Intelligence Health Risk Management Platform Forecast
10.4.3 UK 麻豆原创 Artificial Intelligence Health Risk Management Platform Forecast
10.4.4 Italy 麻豆原创 Artificial Intelligence Health Risk Management Platform Forecast
10.4.5 Russia 麻豆原创 Artificial Intelligence Health Risk Management Platform Forecast
10.5 Middle East & Africa Artificial Intelligence Health Risk Management Platform Forecast by Region (2025-2030)
10.5.1 Egypt 麻豆原创 Artificial Intelligence Health Risk Management Platform Forecast
10.5.2 South Africa 麻豆原创 Artificial Intelligence Health Risk Management Platform Forecast
10.5.3 Israel 麻豆原创 Artificial Intelligence Health Risk Management Platform Forecast
10.5.4 Turkey 麻豆原创 Artificial Intelligence Health Risk Management Platform Forecast
10.6 Global Artificial Intelligence Health Risk Management Platform Forecast by Type (2025-2030)
10.7 Global Artificial Intelligence Health Risk Management Platform Forecast by Application (2025-2030)
10.7.1 GCC Countries 麻豆原创 Artificial Intelligence Health Risk Management Platform Forecast
11 Key Players Analysis
11.1 IBM
11.1.1 IBM Company Information
11.1.2 IBM Artificial Intelligence Health Risk Management Platform Product Offered
11.1.3 IBM Artificial Intelligence Health Risk Management Platform Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.1.4 IBM Main Business Overview
11.1.5 IBM Latest Developments
11.2 Health Catalyst
11.2.1 Health Catalyst Company Information
11.2.2 Health Catalyst Artificial Intelligence Health Risk Management Platform Product Offered
11.2.3 Health Catalyst Artificial Intelligence Health Risk Management Platform Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.2.4 Health Catalyst Main Business Overview
11.2.5 Health Catalyst Latest Developments
11.3 Verisk
11.3.1 Verisk Company Information
11.3.2 Verisk Artificial Intelligence Health Risk Management Platform Product Offered
11.3.3 Verisk Artificial Intelligence Health Risk Management Platform Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.3.4 Verisk Main Business Overview
11.3.5 Verisk Latest Developments
11.4 Evolent
11.4.1 Evolent Company Information
11.4.2 Evolent Artificial Intelligence Health Risk Management Platform Product Offered
11.4.3 Evolent Artificial Intelligence Health Risk Management Platform Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.4.4 Evolent Main Business Overview
11.4.5 Evolent Latest Developments
11.5 Optum
11.5.1 Optum Company Information
11.5.2 Optum Artificial Intelligence Health Risk Management Platform Product Offered
11.5.3 Optum Artificial Intelligence Health Risk Management Platform Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.5.4 Optum Main Business Overview
11.5.5 Optum Latest Developments
11.6 Ayasdi
11.6.1 Ayasdi Company Information
11.6.2 Ayasdi Artificial Intelligence Health Risk Management Platform Product Offered
11.6.3 Ayasdi Artificial Intelligence Health Risk Management Platform Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.6.4 Ayasdi Main Business Overview
11.6.5 Ayasdi Latest Developments
11.7 Cleerly
11.7.1 Cleerly Company Information
11.7.2 Cleerly Artificial Intelligence Health Risk Management Platform Product Offered
11.7.3 Cleerly Artificial Intelligence Health Risk Management Platform Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.7.4 Cleerly Main Business Overview
11.7.5 Cleerly Latest Developments
11.8 Health at Scale
11.8.1 Health at Scale Company Information
11.8.2 Health at Scale Artificial Intelligence Health Risk Management Platform Product Offered
11.8.3 Health at Scale Artificial Intelligence Health Risk Management Platform Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.8.4 Health at Scale Main Business Overview
11.8.5 Health at Scale Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.